How to access Ztalmy from Saudi Arabia, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
A Saudi Arabia family of a child with CDKL5 deficiency disorder (CDD) may receive a prescription for Ztalmy (ganaxolone) from their treating paediatric neurologist. Ztalmy is FDA-approved, manufactured by Marinus Pharmaceuticals, and is an oral suspension neuroactive steroid indicated for seizures associated with CDKL5 deficiency disorder in patients aged 2 years and older. CDKL5 deficiency disorder is a rare, severe, X-linked developmental and epileptic encephalopathy driven by pathogenic variants in the CDKL5 gene. In Saudi Arabia, Ztalmy is not locally registered, which is why your paediatric neurologist will navigate the Saudi Food and Drug Authority (SFDA) named-patient import pathway on your behalf.
This guide explains the legal pathway, what documentation your physician needs, typical timing and how quotes work, and where Reserve Meds fits in.
Note on substitution: this guide was assigned originally for Epidiolex / India, but Epidiolex (oral cannabidiol pharmaceutical) import into India sits inside the NDPS Act controlled-substance framework that is not practically accessible through a standard named-patient pathway without a dedicated controlled-substance import licence. We have substituted a CDKL5 paediatric-neurology pair that better fits Reserve Meds's cash-pay, non-controlled-substance service scope.
Ask about Ztalmy in Saudi Arabia
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Ztalmy is an oral suspension taken three times daily, dosed by weight. Eligibility is based on clinical diagnosis of CDKL5 deficiency disorder, typically supported by genetic confirmation of a pathogenic variant in CDKL5, with refractory seizures as the primary treatment indication. Treatment requires a paediatric neurologist familiar with developmental and epileptic encephalopathies, with ongoing seizure diary tracking, liver function monitoring, and coordination of concomitant antiseizure medications. Because Ztalmy is oral, in-country administration is straightforward once the prescribing plan is in place.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Ztalmy legally importable into Saudi Arabia?
Yes, through the SFDA named-patient import framework, administered in coordination with the Ministry of Health for patients treated in public tertiary centres.
The named-patient mechanism allows a Saudi Arabia-licensed physician to import a medicine not locally registered when: (a) the medicine is approved by a recognised reference authority such as the US FDA, (b) no clinically equivalent locally registered alternative is available, (c) the physician takes clinical responsibility, and (d) chain of custody is documented end to end. For CDKL5 deficiency disorder in Saudi Arabia, there is no locally registered disease-specific alternative.
How the pathway works, step by step
- Consultation with your paediatric neurologist. Genetic confirmation of CDKL5 pathogenic variant, clinical diagnosis of CDD, seizure history documentation, and Ztalmy clinical rationale prepared.
- Baseline assessment. Weight, seizure frequency baseline, liver function tests, and current antiseizure regimen documented.
- SFDA named-patient application. Your physician or the hospital pharmacy files the application with clinical rationale, genetic report, patient reference, and chain-of-custody plan.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure Ztalmy from Marinus's authorised distribution channel.
- Shipment. Ztalmy ships with chain-of-custody documentation; manufacturer handling conditions apply during transport.
- Arrival and dispensing. The hospital pharmacy releases the bottle to the family with weight-based dosing instructions and seizure-diary coaching.
What documentation your physician needs
Your physician will typically need to provide:
- A clinical rationale letter confirming CDD diagnosis, CDKL5 genetic report, baseline seizure profile, current antiseizure regimen, and Ztalmy as the indicated treatment
- Verification of their Saudi Arabia medical licence (SCFHS / MOH)
- A copy of the CDKL5 genetic diagnostic report
- Patient identifier (anonymised reference where possible)
- An administration and monitoring plan including weight-based dosing, liver function surveillance, and seizure-diary cadence
Reserve Meds provides a physician documentation kit that bundles the templates SFDA reviewers expect to see for rare-paediatric-neurology named-patient imports, including the seizure-diary and liver-function surveillance plan central to Ztalmy.
Costs and timing
Ztalmy is weight-dependent in dosing, so annual cost scales with the child's body weight. Medicine price: quote on request. You get a written quote for your case before you commit. International logistics, SFDA documentation handling, and coordination add incremental cost. Reserve Meds issues a full transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Refills ship on a rolling basis against the monthly dispensing schedule.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
A culturally-aware note: CDKL5 deficiency disorder is primarily a condition of girls, and the caregiving journey is a multi-year, round-the-clock family effort, mothers, fathers, grandmothers, and paid caregivers often share day and night shifts. In Saudi Arabia families, multigenerational caregiving with strong grandmother and aunt involvement is typical. Our coordination supports the extended caregiving network: a designated case lead briefs everyone the primary caregiver nominates, with refill logistics aligned to school terms, Hajj, and Ramadan.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Ztalmy specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and for SFDA review.
- Logistics. Chain-of-custody shipment coordination to your prescribing hospital pharmacy.
- Dedicated case lead. A named point of contact for the family, coordinating long-term refills and weight-based dose adjustments as the child grows.
What we do not do: we are not the prescriber, we do not practise medicine, and we are not the dispensing pharmacy. All clinical decisions remain with your treating paediatric neurologist.
Frequently asked
Is this legal in Saudi Arabia? Yes, when executed through the SFDA named-patient framework with appropriate documentation. Cross-border named-patient import for rare-paediatric-neurology therapies is a recognised mechanism. See our trust and compliance page.
Is Ztalmy a cure? No. Ztalmy reduces seizure frequency in CDD. It is used alongside, not instead of, the broader antiseizure regimen your neurology team manages. Your paediatric neurologist will discuss realistic outcome expectations.
What side effects should we watch for? Somnolence is the most commonly reported side effect. Your neurologist will coach on dose-titration strategy and monitoring.
Does Ztalmy interact with other antiseizure medications? Yes, drug-interaction review is part of the standard workup. Your neurologist manages the interaction profile.
Will insurance or MoH coverage apply? Cash-pay is the default. Some Saudi Arabia patients may receive partial MoH or private-insurance consideration on a case-by-case basis; we supply documentation for submission but do not process claims directly.
Next step
For Ztalmy coordination in Saudi Arabia, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
Composite case examples. This content is for general information and does not constitute medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Frequently asked questions
How can I get Ztalmy in Saudi Arabia if it is not approved or available there?
Reserve Meds coordinates US-sourced Ztalmy for patients in Saudi Arabia through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for Saudi Arabia and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Ztalmy in Saudi Arabia through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Ztalmy. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in Saudi Arabia, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Ztalmy in Saudi Arabia through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Ztalmy to a patient in Saudi Arabia?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Ztalmy to your treating physician or hospital pharmacy in Saudi Arabia, with appropriate handling for the product.
How long does it take, and what does Ztalmy in Saudi Arabia cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Ztalmy in Saudi Arabia?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.